Aims: To investigate the feasibility of hyperthermic isolated regional perf
usion (HIRP) with carboplatin in the management of locally recurrent and/or
intransit metastases of melanoma or locally advanced soft tissue sarcoma.
Methods: Three patients, two with locally advanced melanoma and one with a
low-grade liposarcoma of the lower extremity, were treated with HIRP under
mild hyperthermia (39-40 degreesC) with 125mg carboplatin/l perfused limb v
olume.
Results: No systemic toxicity was observed. Local toxicity consisted of pos
t-perfusion oedema present in all three patients which resolved within 2 we
eks. Clinically, a persistent local neuropathy was observed in all three pa
tients, two of which were confirmed by electromyogram and nerve conduction
study. Severe motor-sensory neuropathy was located mainly in the peroneal a
nd sural nerves of the perfused limbs. Pharmacokinetic parameters of the ca
rboplatin showed a higher concentration of carboplatin in the skin compared
to the muscle. The two melanoma patients showed a complete response but de
veloped local recurrences within 1.5 years after perfusion. The third patie
nt underwent a delayed excision of the sarcoma 8 weeks after perfusion whic
h revealed 50% viable tumour. One of the melanoma patients and the sarcoma
patient died from lung metastases 56 and 31 months pest-perfusion treatment
, respectively. The other melanoma patient is alive 95 + months post-perfus
ion treatment.
Conclusions: The local neurotoxicity observed did not warrant further resea
rch of carboplatin in HIRP. (C) 2000 Harcourt Publishers Ltd.